WO2009005115A1 - 脂肪細胞の小型化促進用組成物 - Google Patents

脂肪細胞の小型化促進用組成物 Download PDF

Info

Publication number
WO2009005115A1
WO2009005115A1 PCT/JP2008/062044 JP2008062044W WO2009005115A1 WO 2009005115 A1 WO2009005115 A1 WO 2009005115A1 JP 2008062044 W JP2008062044 W JP 2008062044W WO 2009005115 A1 WO2009005115 A1 WO 2009005115A1
Authority
WO
WIPO (PCT)
Prior art keywords
adipocyte
composition
plant
reduction
size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/062044
Other languages
English (en)
French (fr)
Inventor
Shigeru Hiramoto
Satomi Sasaki
Kazuhiro Maejima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Pharma Inc
Nippon Shinyaku Co Ltd
Original Assignee
Nisshin Pharma Inc
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Pharma Inc, Nippon Shinyaku Co Ltd filed Critical Nisshin Pharma Inc
Priority to JP2009521657A priority Critical patent/JPWO2009005115A1/ja
Publication of WO2009005115A1 publication Critical patent/WO2009005115A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)

Abstract

　脂肪細胞が脂肪を蓄積して肥大化するのを抑制でき、かつ副作用の心配がなく安全性が高い上に、簡便に摂取可能かつ長期間の継続的摂取が容易である組成物を提供する。 　本発明は、キク科バラモンジン属（Tragopogon）に属する植物およびキク科フタナミソウ属（Scorzonera）に属する植物から選択される少なくとも１種の植物、またはその抽出物を有効成分として含む、脂肪細胞の脂肪蓄積抑制用の組成物、脂肪細胞の小型化促進化用組成物、脂肪細胞の分化抑制用組成物、ならびに肥満および／またはメタボリックシンドロームを予防および／または改善するための組成物に関する。
PCT/JP2008/062044 2007-07-03 2008-07-03 脂肪細胞の小型化促進用組成物 Ceased WO2009005115A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009521657A JPWO2009005115A1 (ja) 2007-07-03 2008-07-03 脂肪細胞の小型化促進用組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007175339 2007-07-03
JP2007-175339 2007-07-03

Publications (1)

Publication Number Publication Date
WO2009005115A1 true WO2009005115A1 (ja) 2009-01-08

Family

ID=40226156

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/062044 Ceased WO2009005115A1 (ja) 2007-07-03 2008-07-03 脂肪細胞の小型化促進用組成物

Country Status (2)

Country Link
JP (1) JPWO2009005115A1 (ja)
WO (1) WO2009005115A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345646A1 (en) * 2010-01-14 2011-07-20 InterMed Discovery GmbH Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1927301A (zh) * 2006-09-05 2007-03-14 江西本草天工科技有限责任公司 通脉降脂分散片及其制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1927301A (zh) * 2006-09-05 2007-03-14 江西本草天工科技有限责任公司 通脉降脂分散片及其制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BULL. ACAD. MED., vol. 87, 1922, pages 721 *
DATABASE CAPLUS [online] Database accession no. (2007:317226) *
DATABASE CAPLUS [online] DUMONT J.: "Diet in diabetes", accession no. STN Database accession no. (1922:24932) *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345646A1 (en) * 2010-01-14 2011-07-20 InterMed Discovery GmbH Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
WO2011085979A1 (en) * 2010-01-14 2011-07-21 Intermed Discovery Gmbh Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions

Also Published As

Publication number Publication date
JPWO2009005115A1 (ja) 2010-08-26

Similar Documents

Publication Publication Date Title
Morgan et al. Reactive oxygen species in TNFα-induced signaling and cell death
WO2009152189A8 (en) Low dose topiramate/phentermine compostion and methods of use thereof
HK1216506A1 (zh) 含硒組合物及其治療和預防與線粒體功能障礙有關的疾病或病症的應用
WO2010134756A3 (ko) 녹차 추출물을 함유하는 조성물
WO2010100653A8 (en) Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
WO2009048249A3 (en) Composition for preventing or treating lipid metabolic disorders comprising fucoxanthin or marine plant extract containing same
MX2012002343A (es) Agente contra la obesidad, alimento o bebida contra la obesidad, agente que mejora la tolerancia a la glucosa, y alimento o bebida para mejorar la tolerancia a la glucosa.
EP2014295A3 (en) Topical compositions for the prevention and treatment of inflammatory and/or infective conditions of the genital area
WO2008139699A1 (ja) 劣化臭防止剤および抗菌剤
WO2011095882A8 (en) Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency
WO2011043631A3 (ko) 호장근 추출물, 이의 분획물 또는 스틸벤계 화합물을 포함하는 감기의 예방 및 치료용 약학 조성물
MX2011011860A (es) Composicion estimulante inmune que comprende un extracto de aronia sp. en combinacion con selenio y/o zinc.
WO2011065791A3 (ko) 황기 추출물을 포함하는 대사 촉진 조성물
WO2011126342A3 (ko) 대잎둥굴레 또는 층층갈고리둥굴레 추출물의 신규한 용도
WO2008108285A1 (ja) ペプチド
JP2011504921A5 (ja)
MY150842A (en) Cocoa extract for use in providing skin benefits
WO2009005115A1 (ja) 脂肪細胞の小型化促進用組成物
WO2012134172A3 (ko) 오미자 에틸아세테이트 분획물 또는 이로부터 분리한 우웨이지수 ｃ를 유효성분으로 포함하는 비만 예방 또는 치료용 조성물
WO2007093853A3 (en) Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols
WO2011141113A3 (de) Kombination aus vitamin k und nikotinamid
WO2009153500A3 (fr) Compositions a base de plantes et utilisations
WO2012144854A3 (ko) 리코찰콘 ａ의 신규 용도
WO2008117481A1 (ja) 皮膚外用剤及び飲食品
BR112012009351A2 (pt) método para prevenção ou tratamento de disfunções, uso de um extrato vegetal de solanum glaucophyllum, composição alimentar ou de dieta, suplemento alimentar, alimento ou suplemento

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08790837

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009521657

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08790837

Country of ref document: EP

Kind code of ref document: A1